Location History:
- Hsinchu, TW (2014 - 2021)
- Tainan, TW (2020 - 2023)
Company Filing History:
Years Active: 2014-2023
Title: Yung-Chun Chuang: Innovator in Vaccine Development and Immunoassays
Introduction
Yung-Chun Chuang is a prominent inventor based in Tainan, Taiwan. He has made significant contributions to the fields of vaccine development and immunoassays, holding a total of 5 patents. His work focuses on enhancing protection against diseases and improving diagnostic methods.
Latest Patents
One of his latest patents is titled "Composition of subunit dengue vaccine." This invention relates to a composition of subunit dengue vaccine comprising a fusion protein of conjugating or connecting delta C nonstructural protein 1 (NS1ΔC or truncated NS1ΔC) to at least one polypeptide of NS3c (or truncated NS3c) and/or consensus envelope protein domain III (cEDIII). This innovative approach aims to enhance better protection against DENV challenge and alleviate associated pathological effects. Another notable patent is "Isolated monoclonal antibodies and/or antigen-binding fragments thereof against indoxyl sulfate and uses thereof." This invention involves isolated monoclonal antibodies (mAbs) and/or antigen-binding fragments that specifically recognize indoxyl sulfate, a protein-bound uremic toxin. The uses of such isolated anti-IS mAbs and/or antigen-binding fragments are aimed at creating immunoassay methods applied in the theragnosis of IS-related diseases.
Career Highlights
Yung-Chun Chuang has worked with notable organizations such as Leadgene Biomedical, Inc. and National Cheng-kung University. His experience in these institutions has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Some of his coworkers include Trai-Ming Yeh and Yu-Wei Cheng. Their collaborative efforts have further advanced the research and development of innovative solutions in their respective fields.
Conclusion
Yung-Chun Chuang is a distinguished inventor whose work in vaccine development and immunoassays has made a significant impact. His innovative patents and collaborations highlight his commitment to advancing medical science and improving public health.